Pancreatic Cancer Research

ResearcherUniversity of Campania "Luigi Vanvitelli"Active in the last 2 years

Ugo Chianese

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2726-1895; OpenAlex author ID A5047700685. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41392-025-02546-8↗
  2. Targeting the Tumor-Stroma Crosstalk: An AI-Based Virtual Screening Strategy for Dual MET/SMO Inhibitors in Pancreatic Cancer First author DOI 10.64898/2026.07.03.736313↗
  3. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers14153799↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosaria Benedetti · 3 shared papers, 2022–2026 · strength 0.62
  2. Stefania Scala · 1 shared paper, 2026 · strength 0.24
  3. Fortunato Ciardiello · 1 shared paper, 2026 · strength 0.24
  4. Sandro Cosconati · 1 shared paper, 2026 · strength 0.24
  5. Floriana Morgillo · 1 shared paper, 2026 · strength 0.24
  6. Crescenzo D’Alterio · 1 shared paper, 2026 · strength 0.24
  7. Michele Roggia · 1 shared paper, 2026 · strength 0.24
  8. Enza Lonardo · 1 shared paper, 2026 · strength 0.23
  9. Ferdinando De Vita · 1 shared paper, 2026 · strength 0.23
  10. Ahmad Hassan Ali · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.